Penn Davis McFarland’s Pfizer PFE Stock Holding History

Penn Davis McFarland’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.08M	Sell	169,415 -946	-0.6%	-$24.7K	0.36%	38
2026 Q1	$4.78M	Sell	170,361 -971	-0.6%	-$25.9K	0.47%	37
2025 Q4	$4.27M	Buy	171,332 +57,777	+51%	+$1.46M	0.41%	37
2025 Q3	$2.89M	Sell	113,555 -6,810	-6%	-$168K	0.3%	41
2025 Q2	$2.92M	Buy	120,365 +20,295	+20%	+$473K	0.33%	40
2025 Q1	$2.54M	Sell	100,070 -390	-0.4%	-$10.2K	0.3%	43
2024 Q4	$2.67M	Sell	100,460 -1,370	-1%	-$37.2K	0.29%	46
2024 Q3	$2.95M	Buy	+101,830	New	+$2.97M	0.33%	41
2021 Q2	–	Sell	-6,107	Closed	-$221K	–	51
2021 Q1	$221K	Sell	6,107 -6,000	-50%	-$213K	0.04%	46
2020 Q4	$446K	Sell	12,107 -289	-2%	-$10.6K	0.1%	35
2020 Q3	$432K	Buy	+12,396	New	+$435K	0.11%	33
2020 Q1	–	Sell	-6,072	Closed	-$226K	–	49
2019 Q4	$226K	Buy	6,072 +200	+3%	+$7.12K	0.07%	42
2019 Q3	$200K	Buy	+5,872	New	+$214K	0.06%	39

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Penn Davis McFarland's PFE Position: Q2 2026 in Review

Penn Davis McFarland reduced its Pfizer (PFE) stake by 0.56% in Q2 2026, selling an estimated $24.7K and leaving 169,415 shares worth $4.08M. The position accounts for 0.36% of the portfolio, ranked #38.

Penn Davis McFarland first reported a position in PFE in Q3 2019 and has held it in 13 quarters since. The position peaked at $4.78M in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Penn Davis McFarland held 169,415 shares of Pfizer worth $4.08M as of Q2 2026.
Penn Davis McFarland sold 946 Pfizer shares in Q2 2026, an estimated $24.7K.
Pfizer made up 0.36% of Penn Davis McFarland's portfolio in Q2 2026, its #38 holding.
Penn Davis McFarland first reported a position in Pfizer in Q3 2019 and has held it in 13 quarters since.
Penn Davis McFarland's Pfizer position peaked at $4.78M in Q1 2026.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.